Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome

  • Original Article
  • Published:
Journal of Parasitic Diseases Aims and scope Submit manuscript

Abstract

Metronidazole is the most-used pharmaceutical for the treatment of infection by Blastocystis. However, studies have reported resistance of the microorganism towards this pharmaceutical. In Mexico, studies concerning the prevalence of this parasite and its relationship to Irritable Bowel Syndrome have been carried out. To evaluate the in vitro effect of metronidazole and the compound 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol over Blastocystis, as well as the prevalence of Blastocystis in patients with Irritable Bowel Syndrome. A prospective, transversal design study (April 2016–April 2017) of 51 samples of patients with Irritable Bowel Syndrome, obtained from the ISSEMyM Medical Center in Toluca, Mexico. For the identification of Blastocystis was done in three serial stool samples through direct microscopic examination and the Ritchie technique. The in vitro susceptibility test towards metronidazole and the triazolic compound was done through a microculture in concentrations of 1 to 1000 µg/mL, each one in triplicate. A 31.3% prevalence of Blastocystis was observed in the population, with greater prevalence in women (30.2%) than in men (25%). In the susceptibility test, a CL50 of 64 µg/mL was obtained for metronidazole, in comparison to the CL50 of 250 µg/mL for 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol. This molecule in development has an effect for the treatment of infection by Blastocystis in vitro in patients with IBS and therefore, more studies should be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  • Aguilar C, Lucia J (2009) An overview of Blastocystis hominis infection and published experience in hemophilic population. J Coag Disorders 1(1):1–4

    Google Scholar 

  • Alarcón RSR, Amato Neto V, Gakiya E, Bezerra RC (2007) Observações sobre Blastocystis hominis e Cyclospora cayetanensis em exames parasitológicos efetuados rotineiramente. Rev Soc Med Trop 40:253–255

    Article  Google Scholar 

  • Barassa B, Bueno VS (2000) Estudo comparativo entre os métodos de centrífugo-flutuação e de centrífugo-sedimentação no diagnóstico coproparasitológico. Lecta-USF 18:65–73

  • Batista L, Pérez J, Rosinach M, Gonzalo E, Sainz E, Loras C, Forné M, Esteve M, Fernández F (2017) Low efficacy of metronidazole in the eradication of Blastocystis hominis in symtomatic patients: case series and systmatic literatura reviw. Gatroenterol Hepatol 40(6):381–387

    Article  Google Scholar 

  • Beyham Y, Yilmaz H, Cengiz Z, Ekici A (2015) Clinical significance and prevalence of Blastocystis hominis in Van, Turkey. Saudi Med J. 9(36):1118–1121

    Article  Google Scholar 

  • Das R, Khalil S, Mirdha B, Makharia G, Dattagupta S, Chaudhry R (2016) Molecular characterization and subtyping of Blastocystis species in irritable bowel syndrome patients from North India. PLoS ONE 11(1):e0147055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dogruman A, Simsek Z, Boorom K, Ekici E, Tuncer C, Kustimur (2010) Comparison of methods for detection of Blastocytsis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankira, Turkey. PLoS One 5(11):e15484. https://doi.org/10.1371/journal.pone.0015484v

    Article  Google Scholar 

  • Duda A, Kosick D, Lanocha N, Kolodziejczyk L, Lanocha A (2015) The prevalence of Blastocystis hominis and other protozoan parasites in soldiers returning from peacekeeping missions. Am J Trop Med Hyg 92(4):805–806

    Article  PubMed  PubMed Central  Google Scholar 

  • González J, Pérez VM, Jiménez DO, Lopez-Valdez G, Corona D, Cuevas-Yañez E (2011) Effect of temperature on triazole and bistriazole formation through copper-catalyzed alkyne–azide cycloaddition. Tetrahedron Lett 52:3514

    Article  CAS  Google Scholar 

  • Jiménez G, Martínez F, Reyes G, Ramírez M, Arroyo E, Romero V, Stark D, Souza S, Martínez H, Elisser A, Olivo A, Maravilla P (2012) Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population population. Parasitol Res 110(3):1269–1275. https://doi.org/10.1007/s00436-011-2626-7

    Article  Google Scholar 

  • Keri R, Patil S, Budagumpi S, Nagaraja B (2015) Triazole: a promisisng agent. Chem Biol Drug Des 86(4):410–423

    Article  CAS  PubMed  Google Scholar 

  • Khoshnood S, Rafiei A, Saki J, Alizadeh K (2015) Prevalence and genotype characterization of Blastocystis hominis among the Baghmalek people in Southwestern Iran in 2013–2014. Microbiol. 8(10):e23930

    Google Scholar 

  • Kurt Ö, Al FD, Tanyüksel M (2016) Eradication of Blastocystis in humans: Really necessary for all. Parasitol Int 65(6):797–801

    Article  CAS  PubMed  Google Scholar 

  • Longstreth G, Thompson W, Chey W, Hougton L, Mearin E, Spiller R (2006) Functional bowel disorders. Gastroenterology 130(5):1480–1491. https://doi.org/10.1053/j.gastro.2005.11.061

    Article  PubMed  Google Scholar 

  • Mearin F, Ciriza C, Mínguez M, Rey E, Mascort J, Peña E, Cañones P, Júdez J (2016) Guía de Práctica Clínica: síndrome del intestino irritable con estreñimiento y estreñimiento funcional en adultos. Rev Esp Enferm Dig 6(108):332–363

    Google Scholar 

  • Miceli M, Kauffman C (2015) Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis 61(10):1558–1565

    Article  CAS  PubMed  Google Scholar 

  • Mirza H, Tan K (2014) Intra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis 8(5):e2885. https://doi.org/10.1371/journal.pntd.0002885

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mirza H, Upcroft DJ, Tan K (2011) A rapid, high-throughput viability assay for Blastocystis spp reveals metronidazole resistances and extensive subtipe-dependent variations in drug susceptibilities. Antimicrob Agents Chemother 2(5):637–648

    Article  CAS  Google Scholar 

  • Mostafa S, Abd K, Salah Z, Mostafa S (2015) Prevalence and diagnostic approach for a nebleted protozoo Blastocystis hominis. Asian Pac J Trop Dis 5(1):51–59. https://doi.org/10.1016/S2222-1808(14)60626-5

    Article  Google Scholar 

  • Occhipinti K, Smith J (2012) Irritable bowel syndrome: a review and update. Clin Colon Rectal 25:46–52

    Article  Google Scholar 

  • Phillips BP, Zierdt CH (1976) Blastocystis hominis: pathogenic potential in human patients and in gnotobiotes. Exp Parasitol 39(3):358–364

    Article  CAS  PubMed  Google Scholar 

  • Quinlivan J, Wu Jy, Upmacis R (2015) Crystal structure of metronidazolium tetrachloridoaurate. Acta Cryst 71:810–812

    CAS  Google Scholar 

  • Rajic B, Arapovic J, Raguz K, Boskovic M, Babic S, Maslac S (2015) Eradication of Blastocystis hominis prevents the development of simtomatic Hashimoto’s thyroiditid: a case report. J Infect Dev Ctries 9(7):788–791

    Article  CAS  PubMed  Google Scholar 

  • Ramirez M, Hernandez R, Lopez E, Moncada D, Rodriguez A, Pagaza C, Gonzales A, Flisser A, Kawa A, Maravilla P (2010) Parasites in Mexican patients with irritable bowel síndrome: a case-control study. Parasit Vectors 96(3):1–3

    Google Scholar 

  • Roberts T, Stark D, Harkness Jy, Ellis J (2014) Update on the pathogenic potencial and treatment options for Blastocystis sp. Gut Pathogens 6:17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Roberts T, Bush S, Ellis J, Harkness J, Stark D (2015) In vitro antimicrobial susceptibility patterns of Blastocystis. Antimicrob Agents Chemother 59(8):4417–4423. https://doi.org/10.1128/AAC.04832-14 Epub 2015 May 18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schmulson and Drossman (2017) What is new in Rome IV. J Neorogastroenterol Motility 33(2):2093–2887

    Google Scholar 

  • Sekar U, Shanthi M (2013) Blastocystis: consensus of treatment and controversies. Trop Parasitol 3(1):35–39

    Article  PubMed  PubMed Central  Google Scholar 

  • Shawky A, Maha M, Reham A, Mohamed H (2011) The pathogenic role of different Blastocystis hominis genotypes isolated from patients with irritable bowel syndrome. Arab J Gastroenterol 12:194–200

    Article  Google Scholar 

  • Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale G, Amvrosiadis G, Rossi F, Lo monte A, Rizzo A, Raimondo D (2016) Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 7:2242–2255

    Article  CAS  Google Scholar 

  • Stark D, Van Hal S, Marriott D, Ellis J, Harkness J (2007) Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 37:11–20

    Article  CAS  PubMed  Google Scholar 

  • Stensvold R, Brillowska D, Nielsen H, Arendrup M (2006) Detection of Blastocystis hominis in unpreserved stool specimens by using polymerase chain reaction. J Parasitol 92(5):1081–1087. https://doi.org/10.1645/GE-840R.1

    Article  CAS  PubMed  Google Scholar 

  • Strober W (2001) Trypan blue exclusion test of cell viability. Curr Prot Immunol 21(3B):A.3B.1–A.3B.2

    Google Scholar 

  • Tamalee R, Ellis J, Harkness J, Marriott D, Stark D (2014) Treat failure in patients with chronic Blastocystis infection. J Med Microbiol 63:252–257. https://doi.org/10.1099/jmm.0.065508-0

    Article  Google Scholar 

  • Tamalee R, Stephen B, Ellis J, Harkness J, Stark D (2015) In vitro antimicrobial susceptibility patterns of Blastocystis. Anitimicrob Agents Chemother 59(8):4417–4423. https://doi.org/10.1128/AAC.04832-14

    Article  CAS  Google Scholar 

  • Tan KS (2008) New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 21(4):639–665

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tungtrongchitr A, Manatsathi S, Kositchaiwat C, Ongrotchanakun J, Munkong N, Chinabutr P, Leelakusolvong E, Chaicumpa W (2004) Blastocystis hominis infection in irritable bowel síndrome patients. Southeast Asian J Trop Med Public Health 35(3):705–710

    PubMed  Google Scholar 

  • Ustün Sy, Turgay N (2006) Blastocystis hominis and bowel diseases. Turkiye Parasitol Derg 30(1):72–76

    Google Scholar 

  • Wu Z, Mirza H, Tan K (2014) Intra-Subtype variation in enteroadhesion accounts for differences in epitelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7. PLoS Negl Trop Dis 8(5):e2885. https://doi.org/10.1371/journal.pntd.0002885

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yakoob J, Jafri W, Jafri N, Khan R, Islam M, Beg M, Zaman V (2004) Irritable bowel síndrome: in search of an etiology: role of Blastocystis hominis. Am J Trop Med Hyg 70(40):383–385

    Article  PubMed  Google Scholar 

  • Yakoob J, Abbas Z, Asim M, Naz S, Awan S, Hamid S, Jafri W (2011) In vitro sensitive of Blastocystis hominis to garlic, ginger, White cumin, and black pepper used in diet. Parasitol Res 109:379–385

    Article  PubMed  Google Scholar 

  • Ye W, Yao Q, Yu S, Gong P, Qin M (2017) Synthesis and antitumor activity of triazole—containing srafennib analogs. Molecules 22(10):E1759

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

To CONACyT, chemist Zamudio-Chávez of HGI Valentín Gómez Farías, to the Zamser Clinical Analysis Laboratory of Ixtlahuaca and to Caballero-Vásquez, P.MD, of the ISSEMyM Medical Center of Toluca, Mexico.

Author information

Authors and Affiliations

  1. Faculty of Chemistry, Autonomous University of the State of Mexico (UAEMex), Paseo Colón esq Paseo Tollocan, Col. Residencial Colón, Toluca, C.P. 50000, Mexico

    L. García-Flores, JG Santillán-Benítez, E. Cuevas-Yáñez & E. Morales-Ávila

  2. ISSEMyM Medical Center, Av. Baja Velocidad Km. 57.5 Carr. Méx./Tol. # 284 Col San Jerónimo Chicahualco. Municipio, Metepec, Mexico

    JG Santillán-Benítez & P. Caballero-Vásquez

  3. HGI Valentín Gómez Farías, Ixtlahuaca, Mexico

    S. Zamudio-Chávez

Authors
  1. L. García-Flores
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JG Santillán-Benítez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Cuevas-Yáñez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Caballero-Vásquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Zamudio-Chávez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Morales-Ávila
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GF-L, ZC-S and SB-JG collected the samples and performed the coprological assays. GF-L, performed inoculation parasites, viability of the cells and determination of MIC, CV-P performed the Rome IV criteria used for the diagnosis of IBS. CY-E performed the Synthesis of the molecule. SB-JG and MA-E formulated the idea and MA-E, contributed with critical comments. GF-L and SB-JG obtained the authorizations. All authors participated during the discussion and writing of the manuscript and approved its final version.

Corresponding author

Correspondence to JG Santillán-Benítez.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethics approval

The Ethics and Research Committee of the Medical Center ISSEMyM approved the study Reference Number 015/16.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

García-Flores, L., Santillán-Benítez, J., Cuevas-Yáñez, E. et al. Evaluation of the effect of 1,3-bis-(4-phenyl-[1,2,3] triazole-1-il)2-propanol in comparison with metronidazole in an in vitro culture of Blastocystis in samples of patients with irritable bowel syndrome. J Parasit Dis 43, 506–512 (2019). https://doi.org/10.1007/s12639-019-01118-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12639-019-01118-2

Keywords

Search

Navigation